7.4 C
New York
Monday, November 16, 2026

F.D.A. Rejects Closely Watched Lung Cancer Drug From China

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development. The Food and Drug Administration rejected a first-of-its-kind cancer drug that was invented in China, a setback for a medicine that had become a symbol of China’s ascendance as a powerhouse in drug …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

148,415FansLike
396,312FollowersFollow
4,720SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x